Wallace Capital Management Inc. Pfizer Inc Transaction History

Wallace Capital Management Inc.

$646 Million
Q2 2024

A detailed history of Wallace Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Wallace Capital Management Inc. holds 10,190 shares of PFE stock, worth $291,128. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,190

Previous 10,190 -0.0%

Holding current value

$291,128

Previous $285,000 -0.0%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $17,682 - $20,720	700 Added 7.38%	10,190 $285,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $245,696 - $282,137	9,490 New	9,490 $263,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $6,184 - $8,050	157 Added 2.67%	6,040 $246,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $40,539 - $52,919	-971 Reduced 14.17%	5,883 $301,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $43,278 - $52,832	-989 Reduced 12.61%	6,854 $300,000
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $186 - $220	4 Added 0.05%	7,843 $397,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $183 - $226	4 Added 0.05%	7,839 $379,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $165 - $245	4 Added 0.05%	7,835 $463,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $157 - $201	4 Added 0.05%	7,831 $337,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $179 - $203	5 Added 0.06%	7,827 $306,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $200 - $226	6 Added 0.08%	7,822 $294,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $16,735 - $21,280	500 Added 6.83%	7,816 $288,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $3,621 - $4,109	-110 Reduced 1.48%	7,316 $287,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $29,565 - $38,338	-910 Reduced 10.92%	7,426 $267,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $3,365 - $3,778	91 Added 1.1%	8,336 $361,000
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $712 - $782	19 Added 0.23%	8,245 $350,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1,961 - $2,236	-51 Reduced 0.62%	8,226 $359,000
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $12,400 - $13,660	-400 Reduced 4.61%	8,277 $295,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,677	8,677 $291,000

Others Institutions Holding PFE

# of Institutions

3,223

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wallace Capital Management Inc. with notifications on news.

Account

Wallace Capital Management Inc. Pfizer Inc Transaction History